ROSEN, LEADING INVESTOR COUNSEL, Encourages AstraZeneca PLC Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm – AZN

Core Viewpoint - Rosen Law Firm is reminding investors who purchased AstraZeneca PLC securities between February 23, 2022, and December 17, 2024, about the upcoming lead plaintiff deadline for a securities class action lawsuit [1] Group 1: Class Action Details - Investors who purchased AstraZeneca securities during the specified Class Period may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [2] - A class action lawsuit has already been filed, and those wishing to serve as lead plaintiff must file with the Court by February 21, 2025 [3] - The lawsuit alleges that AstraZeneca made materially false and misleading statements regarding its business operations and legal risks, particularly related to insurance fraud in China [5] Group 2: Rosen Law Firm's Credentials - Rosen Law Firm emphasizes the importance of selecting qualified legal counsel with a successful track record in securities class actions, highlighting its own achievements in this area [4] - The firm has recovered hundreds of millions of dollars for investors, including over $438 million in 2019 alone, and has been ranked highly for its performance in securities class action settlements [4]